First, hormone-mediated metabolic differences may play a crucial role: The decline in estrogen levels after menopause may weaken its protective effects on vascular endothelial function and insulin sensitivity, whereas an increase in TyG-BMI reflecting IR may further exacerbate endothelial dysfunction and atherosclerosis (32, 33). The gene discussed is INS; the disease is endothelial dysfunction.